Turning off cancer’s growth switches. Interview with Steven Yatomi-Clarke, CEO of Prescient Therapeutics, on targeted medicine
Cancer has been on the public radar for many years now and, although several drugs...
Cancer has been on the public radar for many years now and, although several drugs...
This week we were joined in office by Prescient Therapeutics (ASX: PTX) CEO and Managing...
Humankind has been trying to find a cure for cancer for thousands of years. Today,...
The more prevalent role that algorithms, automation and data have on our day to day...
Over the last decade, technological improvements and algorithmic learning have made rapid improvements to many...
To stay up to date with Prescient Therapeutics news and events, please register your details.